Benefits
Skin (unproven for this ingredient)
Some collagen peptides improve skin hydration and elasticity in trials, but that research used type I peptides, whereas Collamex is mainly type II cartilage collagen, so the skin benefit for this ingredient is unproven and borrowed from a different collagen type.
Joint and connective tissue
As a type II collagen and chondroitin source from cartilage, Collamex targets the same tissue that collagen peptide trials link to reduced joint pain and better function, though those trials used other collagen products, not Collamex itself.
Limited-evidence note
Collagen peptides as a class have supportive research, but dedicated published clinical data for this specific ingredient are limited.
Mechanism of action
Amino acid supply
Collagen peptides deliver glycine, proline, and hydroxyproline, the building blocks the body uses to make its own collagen.
Peptide signaling
Specific collagen peptides may signal skin and cartilage cells to ramp up collagen production.
Clinical trials
Randomized placebo-controlled trial of a generic low-molecular-weight collagen peptide, not Collamex specifically.
Oral collagen peptide 1,000 mg/day for 12 weeks significantly improved skin hydration, wrinkling and elasticity versus placebo. Generic collagen-peptide class evidence, not a Collamex trial.
Randomized placebo-controlled trial of generic collagen peptides in active adults, not Collamex specifically.
Collagen peptides 10 g/day for 6 months significantly improved activities of daily living and pain in active adults. Generic collagen-peptide class evidence, not a Collamex trial.
Randomized placebo-controlled trial of generic type I/III collagen peptides in a patient population, not Collamex specifically.
Collagen peptide supplementation for 8 weeks significantly reduced pain and improved quality of life versus placebo. Generic collagen-peptide class evidence, not a Collamex trial.